These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12055186)

  • 21. Cutting edge: a single MHC anchor residue alters the conformation of a peptide-MHC complex inducing T cells that survive negative selection.
    Peterson DA; DiPaolo RJ; Kanagawa O; Unanue ER
    J Immunol; 2001 May; 166(10):5874-7. PubMed ID: 11342600
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The sites in the I-Ak histocompatibility molecule photoaffinity labeled by an immunogenic lysozyme peptide.
    Luescher IF; Crimmins DL; Schwartz BD; Unanue ER
    J Biol Chem; 1990 Jul; 265(19):11177-84. PubMed ID: 2358457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitation of lysozyme peptides bound to class II MHC molecules indicates very large differences in levels of presentation.
    Velazquez C; DiPaolo R; Unanue ER
    J Immunol; 2001 May; 166(9):5488-94. PubMed ID: 11313387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endogenous and exogenous forms of the same antigen are processed from different pools to bind MHC class II molecules in endocytic compartments.
    Bonifaz LC; Arzate S; Moreno J
    Eur J Immunol; 1999 Jan; 29(1):119-31. PubMed ID: 9933093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Presentation on class II MHC molecules of endogenous lysozyme targeted to the endocytic pathway.
    Parra-López CA; Lindner R; Vidavsky I; Gross M; Unanue ER
    J Immunol; 1997 Mar; 158(6):2670-9. PubMed ID: 9058800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancement of peptide antigen presentation by a second peptide.
    de Kroon AI; McConnell HM
    Proc Natl Acad Sci U S A; 1993 Oct; 90(19):8797-801. PubMed ID: 8105466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficiency of antigen presentation after antigen targeting to surface IgD, IgM, MHC, Fc gamma RII, and B220 molecules on murine splenic B cells.
    Snider DP; Segal DM
    J Immunol; 1989 Jul; 143(1):59-65. PubMed ID: 2471743
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A peptide-binding motif for I-A(g7), the class II major histocompatibility complex (MHC) molecule of NOD and Biozzi AB/H mice.
    Harrison LC; Honeyman MC; Trembleau S; Gregori S; Gallazzi F; Augstein P; Brusic V; Hammer J; Adorini L
    J Exp Med; 1997 Mar; 185(6):1013-21. PubMed ID: 9091575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms and consequences of peptide selection by the I-Ak class II molecule.
    Latek RR; Unanue ER
    Immunol Rev; 1999 Dec; 172():209-28. PubMed ID: 10631948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can one predict antigenic peptides for MHC class I-restricted cytotoxic T lymphocytes useful for vaccination?
    Calin-Laurens V; Trescol-Biémont MC; Gerlier D; Rabourdin-Combe C
    Vaccine; 1993; 11(9):974-8. PubMed ID: 7692684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. mAb against hen egg-white lysozyme regulate its presentation to CD4(+) T cells.
    Guermonprez P; Lo-Man R; Sedlik C; Rojas MJ; Poljak RJ; Leclerc C
    Int Immunol; 1999 Nov; 11(11):1863-72. PubMed ID: 10545490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cathepsin D, but not cathepsin B, releases T cell stimulatory fragments from lysozyme that are functional in the context of multiple murine class II MHC molecules.
    van Noort JM; Jacobs MJ
    Eur J Immunol; 1994 Sep; 24(9):2175-80. PubMed ID: 8088334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Presentation of endogenously synthesized MHC class II-restricted epitopes by MHC class II cancer vaccines is independent of transporter associated with Ag processing and the proteasome.
    Dissanayake SK; Tuera N; Ostrand-Rosenberg S
    J Immunol; 2005 Feb; 174(4):1811-9. PubMed ID: 15699107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Minute quantities of a single immunodominant foreign epitope are presented as large nested sets by major histocompatibility complex class II molecules.
    Vignali DA; Urban RG; Chicz RM; Strominger JL
    Eur J Immunol; 1993 Jul; 23(7):1602-7. PubMed ID: 7686856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective immunosuppression by administration of major histocompatibility complex class II-binding peptides. II. Preventive inhibition of primary and secondary in vivo antibody responses.
    Guéry JC; Neagu M; Rodriguez-Tarduchy G; Adorini L
    J Exp Med; 1993 May; 177(5):1461-8. PubMed ID: 8478615
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Processing of an endogenous protein can generate MHC class II-restricted T cell determinants distinct from those derived from exogenous antigen.
    Moreno J; Vignali DA; Nadimi F; Fuchs S; Adorini L; Hämmerling GJ
    J Immunol; 1991 Nov; 147(10):3306-13. PubMed ID: 1658143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activated antigen-presenting cells select and present chemically modified peptides recognized by unique CD4 T cells.
    Herzog J; Maekawa Y; Cirrito TP; Illian BS; Unanue ER
    Proc Natl Acad Sci U S A; 2005 May; 102(22):7928-33. PubMed ID: 15901898
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Binding of photoreactive lysozyme peptides to murine histocompatibility class II molecules.
    Luescher IF; Allen PM; Unanue ER
    Proc Natl Acad Sci U S A; 1988 Feb; 85(3):871-4. PubMed ID: 3422468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of pH and polysaccharides on peptide binding to class II major histocompatibility complex molecules.
    Harding CV; Roof RW; Allen PM; Unanue ER
    Proc Natl Acad Sci U S A; 1991 Apr; 88(7):2740-4. PubMed ID: 2011583
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition by chloroquine of the class II major histocompatibility complex-restricted presentation of endogenous antigens varies according to the cellular origin of the antigen-presenting cells, the nature of the T-cell epitope, and the responding T cell.
    Lombard-Platlet S; Bertolino P; Deng H; Gerlier D; Rabourdin-Combe C
    Immunology; 1993 Dec; 80(4):566-73. PubMed ID: 7508420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.